Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Lisanne N. van Merendonk"'
Autor:
Pere Fontova, Lisanne N. van Merendonk, Anna Vidal-Alabró, Raül Rigo-Bonnin, Gema Cerezo, Stefaan van Oevelen, Oriol Bestard, Edoardo Melilli, Nuria Montero, Ana Coloma, Anna Manonelles, Joan Torras, Josep M. Cruzado, Josep M. Grinyó, Helena Colom, Nuria Lloberas
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1481 (2023)
Despite intensive monitoring of whole blood tacrolimus concentrations, acute rejection after kidney transplantation occurs during tacrolimus therapy. Intracellular tacrolimus concentrations could better reflect exposure at the site of action and its
Externí odkaz:
https://doaj.org/article/17151f14f7b844a0abfe1718be0a1db2
Autor:
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, Lisanne N. van Merendonk, Anna Vidal-Alabró, Nuria Montero, Edoardo Melilli, Maria Meneghini, Anna Manonelles, Josep M. Cruzado, Juan Torras, Josep Maria Grinyó, Oriol Bestard, Nuria Lloberas
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Tacrolimus is the backbone immunosuppressant after solid organ transplantation. Tacrolimus has a narrow therapeutic window with large intra- and inter-patient pharmacokinetic variability leading to frequent over- and under-immunosuppres
Externí odkaz:
https://doaj.org/article/919fc8842deb4744a8f2acf7f43d07ac
Autor:
Kübra Akgöl, Lisanne N van Merendonk, Hannerieke J Barkman, Dorieke EM van Balen, Hester L van den Hoek, Marjolein G Klous, Jeroen JMA Hendrikx, Alwin DR Huitema, Jos H Beijnen, Bastiaan Nuijen
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311761
Introduction Increasing use of expensive oral anticancer medicines comes with the downside of a financial and environmental burden, partially caused by unused medication. Returned oral anticancer medicine to the pharmacy could be considered for redis
Autor:
Lisanne N. van Merendonk, Josep M. Grinyó, Oriol Bestard, Nuria Lloberas, Josep M. Cruzado, Helena Colom, Anna Vidal-Alabró, Pere Fontova, Raül Rigo-Bonnin, Juan Torras
Publikováno v:
Clinica Chimica Acta. 503:210-217
Rejection and toxicity occur despite monitoring of tacrolimus blood levels during clinical routine. The intracellular concentration in lymphocytes could be a better reflection of the tacrolimus exposure. Four extraction methods for tacrolimus in peri
The potential for deprescribing in a palliative oncology patient population: a cross-sectional study
Autor:
Lisanne N van Merendonk, Bas J M Peters, Julia E Möhlmann, Cornelis B Hunting, Elisabeth A Kastelijn, Marcel P H van den Broek
Publikováno v:
European journal of hospital pharmacy : science and practice.
The use of preventive medication in palliative oncology patients may be inappropriate due to limited life expectancy. Deprescribing tools are available but time-consuming and not always tailored to this specific population. Our primary goal was to id
Autor:
Pierre M. Bet, Monique W J den Brok, Lisanne N van Merendonk, Pieter-Paul Hekking, Daniël A. Korevaar, Anke F Leeuwerik, Christian J Jacobs
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 78(21), 1944-1951. American Society of Health-Systems Pharmacy
van Merendonk, L N, Leeuwerik, A F, den Brok, M W J, Hekking, P-P W, Korevaar, D A, Jacobs, C J & Bet, P M 2021, ' Peripheral infiltration of remdesivir in 3 patients with COVID-19 : Case series and discussion ', American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, vol. 78, no. 21, pp. 1944-1951 . https://doi.org/10.1093/ajhp/zxab197
American journal of health-system pharmacy : AJHP, 78(21), 1944-1951. American Society of Health-Systems Pharmacy
van Merendonk, L N, Leeuwerik, A F, den Brok, M W J, Hekking, P-P W, Korevaar, D A, Jacobs, C J & Bet, P M 2021, ' Peripheral infiltration of remdesivir in 3 patients with COVID-19 : Case series and discussion ', American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, vol. 78, no. 21, pp. 1944-1951 . https://doi.org/10.1093/ajhp/zxab197
American journal of health-system pharmacy : AJHP, 78(21), 1944-1951. American Society of Health-Systems Pharmacy
Purpose The coronavirus disease 2019 (COVID-19) pandemic resulted in accelerated market access to remdesivir worldwide. Therefore, data about complications experienced during use of the drug are limited. This is the first published case series (1 cas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47112f8e6bc464dee6df81d4bea656cf
https://research.vumc.nl/en/publications/40033545-193a-4343-8bcf-e44bd8853338
https://research.vumc.nl/en/publications/40033545-193a-4343-8bcf-e44bd8853338
Autor:
Lisanne N, van Merendonk, Mirjam, Crul
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(4)
Palliative cancer patients can benefit from deprescribing of potentially inappropriate medications (PIMs). Tools and guidelines developed for the geriatric population are mainly available. This systematic review gives an overview of available guideli
Autor:
Didier Meulendijks, Anthonius de Boer, Lisanne N. van Merendonk, Annemieke Cats, Jan H.M. Schellens, Jos H. Beijnen, Maarten J. Deenen, Linda M. Henricks
Publikováno v:
International Journal of Cancer. 144:2347-2354
Carriers of the genetic DPYD*2A variant, resulting in dihydropyrimidine dehydrogenase deficiency, are at significantly increased risk of developing severe fluoropyrimidine-associated toxicity. Upfront DPYD*2A genotype-based dose reductions improve pa
Autor:
Mirjam Crul, Lisanne N. van Merendonk
Publikováno v:
van Merendonk, L N & Crul, M 2021, ' Deprescribing in palliative patients with cancer : a concise review of tools and guidelines ', Supportive Care in Cancer . https://doi.org/10.1007/s00520-021-06605-y
Purpose Palliative cancer patients can benefit from deprescribing of potentially inappropriate medications (PIMs). Tools and guidelines developed for the geriatric population are mainly available. This systematic review gives an overview of available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5853d6dc9e4f84e0529b9f7955d5bd7
https://research.vumc.nl/en/publications/5a9866e3-92c2-4869-bdec-1c9d1b2a343b
https://research.vumc.nl/en/publications/5a9866e3-92c2-4869-bdec-1c9d1b2a343b
Autor:
Lisanne N. van Merendonk, Ana Coloma, Helena Colom, Maria Meneghini, Pere Fontova, Anna Manonelles, Carolina Polo, Anna Vidal-Alabró, Gema Cerezo, Edoardo Melilli, Josep M. Cruzado, Oriol Bestard, Nuria Lloberas, Raül Rigo-Bonnin, Joan Torras, Nuria Montero, Josep M. Grinyó
Publikováno v:
Clinical pharmacology and therapeutics. 110(1)
Tacrolimus (Tac) is the cornerstone calcineurin inhibitor in transplantation. Extended-release Meltdose formulation (Tac-LCP) offers better bioavailability compared with immediate-release formulation (Tac-IR). We postulated that the less fluctuating